Literature DB >> 26616056

Insulin dependent apolipoprotein B degradation and phosphatidylinositide 3-kinase activation with microsomal translocation are restored in McArdle RH7777 cells following serum deprivation.

Janet D Sparks1, Amy L Magra2, Jeffrey M Chamberlain2, Colleen O'Dell2, Charles E Sparks2.   

Abstract

Previous studies in rat hepatocytes demonstrated that insulin-dependent apolipoprotein (apo) B degradation (IDAD) is lost when cells are maintained for 3 d under enriched culture conditions. Loss of IDAD correlates with increased expression of protein tyrosine phosphatase 1B (PTP1B) known to be associated with resistance to insulin signaling in the liver. McArdle RH7777 hepatoma (McA) cells cultured in serum containing medium are resistant to IDAD; demonstrate a 30% increase in apo B secretion, and express increased levels of PTP1B protein and mRNA. In addition, insulin-stimulated Class I phosphatidylinositide 3-kinase (PI3K) activity of anti-pY immunoprecipitates is severely blunted. IDAD resistance in McA cells correlates with diminished translocation of insulin-stimulated pY-IRS1 to intracellular membranes. Incubation of McA cells with RK682, a protein tyrosine phosphatase inhibitor, is sufficient to restore IDAD in resistant McA cells. Overall, results further support the importance of Class I PI3K activity in IDAD, and suggest that loss of this activity is sufficient to cause resistance. Although other factors are involved in downstream events including sortilin binding to apo B, autophagy, and lysosomal degradation, loss of signal generation and reduced localization of Class I PI3K to intracellular membranes plays a significant role in IDAD resistance.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apo B; IRS1; IRS2; Liver; PI3K; PTP1B; VLDL

Mesh:

Substances:

Year:  2015        PMID: 26616056      PMCID: PMC4698036          DOI: 10.1016/j.bbrc.2015.11.068

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  27 in total

1.  PI3-kinase activity modulates apo B available for hepatic VLDL production in apobec-1-/- mice.

Authors:  Doru V Chirieac; Nicholas O Davidson; Charles E Sparks; Janet D Sparks
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-06-22       Impact factor: 4.052

2.  Obese Zucker (fa/fa) rats are resistant to insulin's inhibitory effect on hepatic apo B secretion.

Authors:  J D Sparks; C E Sparks
Journal:  Biochem Biophys Res Commun       Date:  1994-11-30       Impact factor: 3.575

3.  Insulin effects on apolipoprotein B production by normal, diabetic and treated-diabetic rat liver and cultured rat hepatocytes.

Authors:  J D Sparks; C E Sparks; L L Miller
Journal:  Biochem J       Date:  1989-07-01       Impact factor: 3.857

4.  Effects of fatty acids on apolipoprotein B secretion by McArdle RH-7777 rat hepatoma cells.

Authors:  J D Sparks; H L Collins; I Sabio; M P Sowden; H C Smith; J Cianci; C E Sparks
Journal:  Biochim Biophys Acta       Date:  1997-07-12

5.  Phosphoinositide 3-kinase activity is necessary for insulin-dependent inhibition of apolipoprotein B secretion by rat hepatocytes and localizes to the endoplasmic reticulum.

Authors:  T L Phung; A Roncone; K L Jensen; C E Sparks; J D Sparks
Journal:  J Biol Chem       Date:  1997-12-05       Impact factor: 5.157

6.  Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes.

Authors:  J D Sparks; C E Sparks
Journal:  J Biol Chem       Date:  1990-05-25       Impact factor: 5.157

7.  Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM.

Authors:  R Malmström; C J Packard; M Caslake; D Bedford; P Stewart; H Yki-Järvinen; J Shepherd; M R Taskinen
Journal:  Diabetologia       Date:  1997-04       Impact factor: 10.122

8.  Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene.

Authors:  M Elchebly; P Payette; E Michaliszyn; W Cromlish; S Collins; A L Loy; D Normandin; A Cheng; J Himms-Hagen; C C Chan; C Ramachandran; M J Gresser; M L Tremblay; B P Kennedy
Journal:  Science       Date:  1999-03-05       Impact factor: 47.728

9.  Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals.

Authors:  G F Lewis; K D Uffelman; L W Szeto; G Steiner
Journal:  Diabetes       Date:  1993-06       Impact factor: 9.461

10.  Liver regrowth and apolipoprotein B secretion by rat hepatocytes following partial hepatectomy.

Authors:  J D Sparks; J P Corsetti; C E Sparks
Journal:  Metabolism       Date:  1994-06       Impact factor: 8.694

View more
  3 in total

1.  Sortilin facilitates VLDL-B100 secretion by insulin sensitive McArdle RH7777 cells.

Authors:  Robert P Sparks; Wayne C Guida; Mark P Sowden; Jermaine L Jenkins; Matthew L Starr; Rutilio A Fratti; Charles E Sparks; Janet D Sparks
Journal:  Biochem Biophys Res Commun       Date:  2016-08-02       Impact factor: 3.575

2.  An Allosteric Binding Site on Sortilin Regulates the Trafficking of VLDL, PCSK9, and LDLR in Hepatocytes.

Authors:  Robert P Sparks; Andres S Arango; Jermaine L Jenkins; Wayne C Guida; Emad Tajkhorshid; Charles E Sparks; Janet D Sparks; Rutilio A Fratti
Journal:  Biochemistry       Date:  2020-11-05       Impact factor: 3.162

3.  Identification of Sortilin Alternatively Spliced Variants in Mouse 3T3L1 Adipocytes.

Authors:  Ashley Lui; Robert Sparks; Rekha Patel; Niketa A Patel
Journal:  Int J Mol Sci       Date:  2021-01-20       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.